Advertisement

Biochemical Aspects

  • Dennis V. Parke

Abstract

Since the earliest observation of the London surgeon, Percivall Pott, in the eighteenth century that contact with soot was associated with scrotal skin cancer in chimney sweeps, a wide variety of agents causing cancer have been discovered. These include an extensive number and variety of organic chemicals, metals, oncogenic viruses, ultraviolet light, X-rays, and other ionizing radiations, which may singly and in various combinations result in malignancies of many different types. The epidemiology of cancer suggests that a high proportion of human malignancies are environmental in origin, as for example the lung cancer due to cigarette smoking, the bladder cancer of chemical workers using 2-naphthylamine or benzidine, and the liver cancer due to eating food contaminated with aflatoxins or nitrosamines. Furthermore, although the importance of radiations and oncogenic viruses in the causation of human cancer should in no way be discounted or minimized, it would seem nevertheless that chemicals comprise the major cause (Miller, 1970; Miller and Miller, 1971; Weisburger and Williams, 1975).

Keywords

Endoplasmic Reticulum Oncogenic Virus Chemical Carcinogen Biochemical Aspect Chemical Carcinogenesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aakvaag, A., Tveter, K. J., Unhjem, O., and Attramadal, A. (1972). Receptors and binding of androgens in the prostate. J. Steroid Biochem. 3: 375–384.PubMedGoogle Scholar
  2. Aisenburg, A. C. (1961). The Glycolysis and Respiration of Tumors. Academic Press, New York.Google Scholar
  3. Allison, A. C. (1969). Lysosomes and cancer. In Lysosomes in Biology and Pathology vol. 2. J. T. Dingle and H. B. Fell, eds., pp. 178–204. North Holland, Amsterdam.Google Scholar
  4. Alvares, A. P., Parli, C. J., and Mannering, G. J. (1973). Induction of drug-metabolism. VI. Effects of phenobarbital and 3-methylcholanthrene administration on N-demethylating enzyme systems of rough and smooth hepatic microsomes. Biochem. Pharmacol. 22: 1037–1045.PubMedGoogle Scholar
  5. Alvares, A. P., Schilling, G. R., and Kuntzman, R. (1968). Differences in the kinetics of benzpyrene hydroxylation by hepatic drug-metabolizing enzymes from phenobarbital and 3-methylcholanthrene-treated rats. Biochem. Biophys. Res. Commun. 30: 588–593.PubMedGoogle Scholar
  6. Barker, K. L. (1967). Cofactor induced synthesis of D-glucose-6-phosphate: NADP oxidoreductase in the uterus. Endocrinology 81: 791–797.PubMedGoogle Scholar
  7. Basu, T. K., Parke, D. V., and Williams, D. C. (1974). Hepatic microsomal drug-metabolising enzymes in rats bearing Guerin carcinoma for various periods Cytobios, 11: 71–74.Google Scholar
  8. Benedict, W. F.. Considine. N., and Nebert, D. W. (1973). Genetic differences in aryl hydrocarbon hydroxylase induction and benzo(a)pyrene-produced tumorigenesis in the mouse. Mol. Pharmacol. 9: 266–277.PubMedGoogle Scholar
  9. Berg, T., and Christoffersen, T. (1974). Early changes induced by 2-acetylaminofluorene in lysosomes in rat liver parenchymal cells. Biochem. Pharmacol. 23: 3323–3329.PubMedGoogle Scholar
  10. Black, O., Cantrell, E. T., Buccino, R. J., and Bresnick, E. (1971). Effects of 3-methylcholanthrene administration on the proteins of endoplasmic reticulum. Biochem. Pharmacol. 20: 2989–2998.PubMedGoogle Scholar
  11. Boyd. H.. Louis, C. J., and Martin, T. J. (1974). Activity and hormone responsiveness of adenyl cyclase during induction of tumors in rat liver with 3’-methyl-4-dimethylaminoazobenzene. Cancer Res. 34: 1720–1725.Google Scholar
  12. Brady, R. O., and Fishman, P. H. (1974). Biosynthesis of glycolipids in virus-transformed cells. Biochim. Biophys. Acta 355: 121–148.PubMedGoogle Scholar
  13. Bresnick, E., and Mossé, H. (1969). Activation of genetic transcription in rat liver chromatin by 3-methyicholanthrene. Mol. Pharmacol. 5: 219–247.PubMedGoogle Scholar
  14. Bullough, W. S. (1974). Chalone control mechanisms. Life Sci. 16: 323–330.Google Scholar
  15. Burke, M. D., and Mayer, R. T. (1975). Inherent specificities of purified cytochrome P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metab. Dispos. 3: 245–253.PubMedGoogle Scholar
  16. Castro, J. E., Lance, E. M., Medawar, P. B., Zanelli, J., and Hunt, R. (1973). Foetal antigens and cancer. Nature (London) 243: 225–226.Google Scholar
  17. Chu, B. C. F., and Lawley, P. D., (1975). Increased urinary excretion of nucleic acid and nicotinamide derivatives by rats after treatment with alkylating agents. Chem. Biol. Interact. 10: 333–338.PubMedGoogle Scholar
  18. Chung, L. W. K., and Coffey, D. S. (1971). Biochemical characterization of prostatic nuclei. II. Relationship between DNA synthesis and protein synthesis. Biochim. Biophys. Acta 247: 584–589.PubMedGoogle Scholar
  19. Cleaver, J. E., and Painter, R. B. (1975). Absence of specificity in inhibition of DNA repair replication by DNA-binding agents, cocarcinogens, and steroids in human cells. Cancer Res. 35: 1773–1778.PubMedGoogle Scholar
  20. Conney, A. H. (1967). Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19: 317–366.PubMedGoogle Scholar
  21. Craddock, V. M. (1973). Induction of liver tumours in rats by a single treatment with nitroso compounds given after partial hepatectomy. Nature (London) 245: 386–388.Google Scholar
  22. Craddock, V. M. (1975). Effects of a single treatment with the alkylating carcinogens dimethylnitrosamine, diethylnitrosamine and methyl methanesulphonate, on liver regenerating after partial hepatectomy. IL Alkylation of DNA and inhibition of DNA replication. Chem. Biol. Interact. 10: 323–332.PubMedGoogle Scholar
  23. Creaven, P. J., and Parke, D. V. (1966). The stimulation of hydroxylation by carcinogenic and non-carcinogenic compounds. Biochem. Pharmacol. 15: 7–16.PubMedGoogle Scholar
  24. Currie, G. A. (1975). Immunological escape of tumours. In Cancer and the Immune Response ( J. Turk, ed.), pp. 56–70. Edward Arnold, London.Google Scholar
  25. Cutts, J. H. (1973). Enzyme activities in regressing estrone-induced mammary tumors of the rat. Cancer Res. 33: 1235–1237.PubMedGoogle Scholar
  26. Davies, P., Fahmy, A. R., Pierrepoint, C. G., and Griffiths, K. (1972). Hormonal effects in vitro on prostatic ribonucleic acid polymerase. Biochem. J. 129: 1167–1169.PubMedGoogle Scholar
  27. DeCloitre, F., Martin, M., and Chauveau, J. (1975). Comparative effect of phenobarbital and 3-methylcholanthrene on azo dye metabolism in rat liver. II. In vivo binding of metabolites to cellular macromolecules. Chem. Biol. Interact. 10: 301–307.PubMedGoogle Scholar
  28. Deichmann, W. E., and Radomski, J. L. (1969). Carcinogenicity and metabolism of aromatic amines in the dog. J. Nat. Cancer Inst. 43: 263–269.PubMedGoogle Scholar
  29. Delaunay, J., and Schapira, G. (1974). Ribosomes and cancer. Biomedicine 20: 327–332.PubMedGoogle Scholar
  30. Dustin, P., Jr. (1972). Cell differentiation and carcinogenesis: A critical review. Cell Tiss. Kinet. 5: 519–533.Google Scholar
  31. Edwards, G. S., and Allfrey, V. G. (1973). Aflatoxin B and actinomycin D effects of histone acetylation and deacetylation in the liver. Biochim. Biophys. Acta 299: 354–366.PubMedGoogle Scholar
  32. Edwards, G. S., and Wogan, G. N. (1970). Aflatoxin inhibition of template activity of rat liver chromatin. Biochim. Biophys. Acta 224: 597–607.PubMedGoogle Scholar
  33. Engelse, L. D., and Emmelot, P. (1971–72). Effects of feeding the carcinogen dimethylnitrosamine on its metabolism and methylation of DNA in the mouse, Chem. Biol. Interact. 4: 321–327.Google Scholar
  34. Farber, E. (1973). Carcinogenesis-Cellular evolution as a unifying thread. Cancer Res. 33: 2537–2550.PubMedGoogle Scholar
  35. Farber, E. (1975). Mechanisms by which chemicals initiate cancer, J. Clin. Pharmacol. 15: 2428.Google Scholar
  36. Farron, F., Hsu, H. H. T., and Knox, W. E. (1972). Foetal-type isoenzymes in hepatic and non-hepatic rat tumours. Cancer Res. 32: 302–308.PubMedGoogle Scholar
  37. Fiala, S., and Fiala, E. S. (1973). Activation by chemical carcinogens of y-glutamyl transpeptidase in rat and mouse liver, J. Nat. Cancer Inst. 51: 151–158.PubMedGoogle Scholar
  38. Fiala, S., Fiala, A. E., and Dixon, B. (1972). y-Glutamyl transpeptidase in transplantable, chemically induced rat hepatomas and spontaneous mouse-hepatomas, J. Nat. Cancer Inst. 48: 1393–1401.Google Scholar
  39. Filipe, M. I., and Branfoot, A. C. (1974). Abnormal patterns of mucus secretion in apparently normal mucosa of large intestine with carcinoma. Cancer 34: 282–290.PubMedGoogle Scholar
  40. Fishman, W. H., Artenstein, M., and Green, S. (1955). The renal β-glucuronidase response to androgens. Endocrinology 57: 646–657.PubMedGoogle Scholar
  41. Franklin, M. R. (1972). Piperonyl butoxide metabolism by cytochrome P-450: Factors affecting the formation and disappearance of the metabolite-cytochrome P-450 complex. Xenobiotica 2: 517–527.PubMedGoogle Scholar
  42. Fujimura, S., Grunberger, D., Carvajal, G., and Weinstein, I. B. (1972). Modifications of ribonucleic acid by chemical carcinogens. Modification of Escherichia coli formylmethionine transfer ribonucleic acid with N-acetoxy-2-acetylaminofluorene. Biochemistry. 11: 3629–3635.PubMedGoogle Scholar
  43. Fujita, T., and Mannering, G. T. (1971). Differences in soluble P-450 hemoproteins from livers of rats treated with phenobarbital and 3-methylcholanthrene. Chem. Biol. Interact. 3: 264–265.PubMedGoogle Scholar
  44. Furst, A., and Haro, R. T. (1969). Possible mechanisms of metal ion carcinogenesis. In: The Jerusalem Symposia on Quantum Chemistry and Biochemistry. Physiochemical Mechanisms of Carcinogenesis. E. D. Bergmann and B. Pullman, eds., Vol. 1, pp. 310–320. Israel Academy of Sciences and Humanities, Jerusalem.Google Scholar
  45. Garner, R. C. (1975). Reduction in binding of “C-aflatoxin B to rat liver macromolecules by phenobarbitone pretreatment. Biochem. Pharmacol. 24: 1553–1556.PubMedGoogle Scholar
  46. Gelboin, H. V., Kinoshita, N., and Wiebel, F. J. (1972). Microsomal hydroxylases: Induction and role in polycyclic hydrocarbon carcinogenesis and toxicity. Fed. Proc. 31: 1298–1309.PubMedGoogle Scholar
  47. Genta, V. M., Kaufman, D. G., Harris, C. C., Smith, J. M., Sporn, M. B., and Saffiotti, V. (1974). Vitamin A deficiency enhances binding of benzo(a)pyrene to tracheal epithelial DNA, Nature (London) 247: 48–49.Google Scholar
  48. Gielen, J. E., and Nebert, D. W. (1971). Microsomal hydroxylase induction in liver cell culture by phenobarbital, polycyclic hydrocarbons, and p,p’-DDT. Science (Washington) 172: 167–169.Google Scholar
  49. Glazer, R. I., Glass, L. E., and Menger, F. M. (1975). Modification of hepatic ribonucleic acid polymerase activities by N-hydroxy-2-acetylaminofluorene and N-acetoxy-2-acetylaminofluorene. Mol. Pharmacol. 11: 36–43.PubMedGoogle Scholar
  50. Goldstein, I. M. (1975). Effects of steroids on lysosomes. Transplant. Proc. 7: 21–24.PubMedGoogle Scholar
  51. Grantham. P. H., Weisburger, J. H., and Weisburger, E. K. (1973). Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide. Food Cosmet. Toxicol. 11: 209–217.Google Scholar
  52. Grimm, W., and Marks, F. (1974). Effect of tumour-promoting phorbol esters on the normal and the isoproterenol-elevated level of adenosine 3′,5′-cyclic monophosphate in mouse epidermis in vivo. Cancer Res. 34: 3128–3134.Google Scholar
  53. Grover, P. L., and Sims, P. (1973). K-region epoxides of polycyclic hydrocarbons: Reactions with nucleic acids and polyribonucleotides. Biochem. Pharmacol. 22: 661–666.PubMedGoogle Scholar
  54. Grunberger, G., Yu, F. L., Grunberger, D., and Feigelson, P. (1973). Mechanism of Nhydroxy-2-acetylaminofluorene inhibition of rat hepatic ribonucleic acid synthesis. J. Biol. Chem. 248: 6278–6281.PubMedGoogle Scholar
  55. Hakomori, S -I. (1975). Structures and organisation of cell surface glycolipids dependency on cell growth and malignant transformation. Biochem. Biophys. Acta 417: 55–89.PubMedGoogle Scholar
  56. Harper, M. E., Fahmy, A. R., Pierrepoint, C. G., and Griffiths, K. (1970a). The effect of some stilboestrol compounds on DNA polymerase from human prostatic tissue. Steroids 15: 89–103.PubMedGoogle Scholar
  57. Harper, M. E., Pierrepoint, C. G., Fahmy, A. R., and Griffiths, K. (1970b). The effect of prostatic metabolites of testosterone and other substances on the isolated deoxyribonucleic acid polymerase of the canine prostate. Biochem. J. 119: 785–786.PubMedGoogle Scholar
  58. Harper, M. E., Pierrepoint, C. G., Fahmy, A. R., and Griffiths, K. (1971). The metabolism of steroids in the canine prostate and testis. J. Endocrinol. 49: 213–223.PubMedGoogle Scholar
  59. Hawks, A., Hicks, R. M., Holsman, J. W., and Magee, P. N. (1974). Morphological and biochemical effects of 1,2-dimethylhydrazine and 1-methylhydrazine in rats and mice. Brit. J. Cancer 30: 429–439.PubMedGoogle Scholar
  60. Hawks, A., and Magee, P. N. (1974). The alkylation of nucleic acids of rat and mouse in vivo by the carcinogen 1,2-dimethylhydrazine. Brit. J. Cancer 30: 440–447.PubMedGoogle Scholar
  61. Hulbert, P. B. (1975). Carbonium ion as ultimate carcinogen of polycyclic aromatic hydrocarbons. Nature (London) 256: 146–148.Google Scholar
  62. Imai, Y., and Siekevitz, P. (1971). A comparison of some properties of microsomal cytochrome P-450 from normal, methylcholanthrene-, and phenobarbital-treated rats. Arch. Biochem. Biophys. 144: 143–159.PubMedGoogle Scholar
  63. Jacobson, M., Lu, A. Y. H., Sernatinger, E., West, S., and Kuntzman, R. (1972). The effect of altering liver microsomal CO-binding hemoprotein composition of pentobarbital-induced anesthesia. Chem. Biol. Interact. 5: 183–189.PubMedGoogle Scholar
  64. Jensen, E. V., and De Sombre, E. R. (1972). Mechanism of action of the female sex hormones. Ann. Rev. Biochem. 41: 203–230.PubMedGoogle Scholar
  65. Johnston, B., Lindup, W. E., Shillingford, J. S., Parke, D. V., and Smith. M. (1975). The pharmacological biochemistry of carbenoxolone. Its effects on gastric mucus. In The Fourth Symposium on Carbenoxolone. Sir Francis Avery Jones and Dennis V. Parke, eds. pp. 3–24. Butterworth, London.Google Scholar
  66. Juchau, M. R., Cram, R. L., Plaa, G. L., and Fouts, J. R. (1965). The induction of benzpyrene hydroxylase in the isolated perfused rat liver. Biochem. Pharmacol. 14: 473–482.Google Scholar
  67. Jungmann, R. A., and Schweppe, J. S. (1972). Binding of chemical carcinogens to nuclear proteins of rat liver. Cancer Res. 32: 952–959.PubMedGoogle Scholar
  68. Kawasaki, H., Nei, H., and Kimoto, E. (1974). Immunological demonstration of serum glycoprotein attached to carcinoma cell surface. Gann 65: 447–449.PubMedGoogle Scholar
  69. Keisari, Y., and Witz, I. P. (1973). Degradation of immunoglobulins by lysosomal enzymes of tumours. 1. Demonstration of the phenomena using mouse tumours. Immunochemistry 10: 565–570.PubMedGoogle Scholar
  70. Kellerman, G., Shaw, C. R., and Luyten-Kellerman, M. (1973). Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med. 289: 934–937.Google Scholar
  71. Keysell, G. R., Booth, J., Grover, P. L., Hewer, A., and Sims, P. (1973). The formation of “K-region” epoxides as hepatic microsomal metabolites of 7-methylbenz(a)anthracene and 7,12-dimethylbenz(a)anthracene and their 7-hydroxymethyl derivatives. Biochem. Pharmacol. 22: 2853–2867.PubMedGoogle Scholar
  72. Khandwala, A. S., and Kasper, C. B. (1973). Preferential induction of aryl hydroxylase activity in rat nuclear envelope by 3-methylcholanthrene. Biochem. Biophys. Res. Commun. 54: 1241–1246.PubMedGoogle Scholar
  73. King, H. W. S., Thompson, M. H., and Brookes, P. (1975). The benzo[a]pyrene deoxyribonucleoside products isolated from DNA after metabolism of benzo[a]pyrene by rat liver microsomes in the presence of DNA. Cancer Res. 34: 1263–1269.Google Scholar
  74. King, R. J. B., and Gordon, J. (1972). Involvement of DNA in the acceptor mechanism for uterine oestradiol receptor. Nature (New Biol.) 240: 185–187.Google Scholar
  75. Kinoshita, N., Shears, B., and Gelboin, H. V. (1973). K-region and non-K-region metabolism of benzo(a)pyrene by rat liver microsomes. Cancer Res. 33: 1937–1944.PubMedGoogle Scholar
  76. Kledzik, G. S., Bradley, C. J., and Meites, J. (1974). Reduction of carcinogen-induced mammary cancer incidence in rats by early treatment with hormones or drugs. Cancer Res. 34: 2953–2956.PubMedGoogle Scholar
  77. Knight, L. A., and Davidson, W. M. (1975). Reduced lymphocyte transformation in early cancer of the breast. J. Clin. Pathol. 28: 372–376.PubMedGoogle Scholar
  78. Knox, W. E. (1967). The enzymatic pattern of neoplastic tissue. Adv. Cancer Res. 10: 117–161PubMedGoogle Scholar
  79. Kouri, R. E., Ratrie, H., and Whitmore, C. E. (1973). Evidence of genetic relationship between susceptibility to 3-methylcholanthrene-induced subcutaneous tumors and inducibility of aryl hydrocarbon hydroxylase. J. Nat. Cancer Inst. 51: 197–200.PubMedGoogle Scholar
  80. Kriek, E. (1972). Persistent binding of a new reaction product of the carcinogen N-hydroxy-N2-acetylaminofluorene with guanine in rat liver DNA in vivo. Cancer Res. 32: 2042–2048.Google Scholar
  81. Krüger, F. W., Preussmann, R., and Niepelt, N. (1971). Mechanism of carcinogenesis with 1aryl-3,3-dialkyltriazene. III. In vivo methylation of RNA and DNA with 1-phenyl-3,3[14C]dimethyltriazene. Biochem. Pharmacol. 20: 529–533.PubMedGoogle Scholar
  82. Kuroki, T., Huberman, E., Marquardt, H., Selkirk, J. K., Heidelberger, C., Grover, P. L., and Sims, P. (1971–72). Binding of K-region epoxides and other derivatives of benz(a)anthracene and dibenz[a,h]anthracene to DNA, RNA and protein of transformable cells. Chem. Biol. Interact. 4: 389–397.Google Scholar
  83. Lanclos, K. D., and Bresnick, E. (1973). Initiation factor activity in liver after 3-methylcholanthrene administration. Drug Metab. Dispos. 1: 239–247.PubMedGoogle Scholar
  84. Lin, J -K., Miller, J. A., and Miller, E. C. (1975). Structures of hepatic nucleic acid-bound dyes in rats given the carcinogen N-methyl-4-aminoazobenzene. Cancer Res. 35: 844–850.PubMedGoogle Scholar
  85. Lu, A. Y. H., and Levin, W. (1972). Partial purification of cytochromes P-450 and P-448 from rat liver microsomes. Biochem. Biophys. Res. Commun. 46: 1334–1339.PubMedGoogle Scholar
  86. Magee, P. N., and Barnes, J. M. (1967). Carcinogenic nitroso compounds, Adv. Cancer Res. 10: 163–246.Google Scholar
  87. McIntire, K. R., Waldmann, T. A., Moertel, C. G. and Go, V. L. W. (1975). a-Foetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res. 35: 991–996.Google Scholar
  88. McLean, A. E. M., and Marshall, A. (1971). Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone, Brit. J. Exp. Pathol. 52: 322–329.Google Scholar
  89. McPherson, F., Bridges, J. W., and Parke, D. V. (1974). In vitro enhancement of hepatic microsomal biphenyl hydroxylation by carcinogens, Nature (London) 252: 488–489.Google Scholar
  90. Mailman, R. B., Tate, L. G., Muse, K. E., Coons, L. B., and Hodgson, E. (1975). The occurrence of multiple forms of cytochrome P-450 in hepatic microsomes from untreated rats and mice. Chem. Biol. Interact. 10: 215–228.PubMedGoogle Scholar
  91. Margison, G. P., and Kleihues, P. (1975). Chemical carcinogenesis in the nervous system. Preferential accumulation of Os-methylguanine in rat brain DNA during repetitive administration of N-methyl-N-nitrosurea, Biochem. J. 148: 521–525.PubMedGoogle Scholar
  92. Marquardt, H., and Heidelberger, C. (1972). Stimulation of DNA synthesis in hydrocarbon-transformable hamster embryo cells by the K-region epoxide of benz(a)anthracene. Chem. Biol. Interact. 5: 69–71.PubMedGoogle Scholar
  93. Metzler, M. (1975). Metabolic activation of diethylstilboestrol: Indirect evidence for the formation of a stilbene oxide intermediate in hamster and rat. Biochem. Pharmacol. 24: 1449–1453.Google Scholar
  94. Miller, H. C., Rector, W., and Hilf, R. (1972). Preliminary enzymatic studies of human benign prostate hypertrophy and prostatic cancer. Invest. Urol. 10: 1–4.PubMedGoogle Scholar
  95. Miller, J. A. (1970). Carcinogenesis by chemicals: An overview. Cancer Res. 30: 559–576.PubMedGoogle Scholar
  96. Miller, J. A., and Miller, E. C. (1965). Metabolism of drugs in relation to carcinogenicity. Ann. N.Y. Acad. Sci. 123: 125–140.PubMedGoogle Scholar
  97. Miller, J. A., and Miller, E. C. (1969). The metabolic activation of carcinogenic aromatic amines and amides. Progr. Exp. Tumour Res. 11: 273–301.Google Scholar
  98. Miller, J. A., and Miller, E. C. (1971). Chemical carcinogenesis: Mechanisms and approaches to its control. J. Nat. Cancer Inst. 47: 1–16.Google Scholar
  99. Miyake, Y., Gaylor, J. L., and Morris, H. P. (1974). Abnormal microsomal cytochromes and electron transport in Morris hepatoma, J. Biol. Chem. 249: 1980–1987.PubMedGoogle Scholar
  100. Moulé, Y., Leasage, V., Darracq, N., and Rousseau, N. (1975). Opposite effects of phenobarbital treatment on aflatoxin B,-induced inhibition of transcription in rat and mouse liver. Biochem. Pharmacol. 24: 1851–1854.PubMedGoogle Scholar
  101. Nebert, D. W. (1969). Changes in aryl hydrocarbon hydroxylase activity and microsomal P-450 during polycyclic hydrocarbon treatment of mammalian cells in culture. Biochem. Biophys. Res. Commun. 36: 885–890.PubMedGoogle Scholar
  102. Nebert, D. W., and Gelboin, H. V. (1968a). Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J. Biol. Chem. 243: 6242–6249.PubMedGoogle Scholar
  103. Nebert, D. W., and Gelboin, H. V. (1968b). Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. II. Cellular responses during enzyme induction. J. Biol. Chem. 243: 6250–6261.PubMedGoogle Scholar
  104. Nebert, D. W., and Bausserman, L. L. (1970). Genetic differences in the extent of aryl hydrocarbon hydroxylase induction in mouse fetal cell cultures. J. Biol. Chem. 245: 6373–6382.PubMedGoogle Scholar
  105. Nebert, D. W., Goujon, F. M., and Gielen, J. E. (1972). Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse. Nature (Neu Biol.) 236: 107–110.Google Scholar
  106. Nimberg, R. B., Glasgow, A. H., Menzoian, J. O., Constantian, M. B., Cooperband, S. R., Mannick, J. A., and Schmid, K. (1975). Isolation of an immunosuppresive peptide fraction from the serum of cancer patients. Cancer Res. 35: 1489–1494.PubMedGoogle Scholar
  107. Okita, K., Gruenstein, M., Klaiber, M., and Farber, E. (1974). Localization of a-foetoprotein by immunofluorescence in hyperplastic nodules during hepatocarcinogenesis induced by 2-acetylaminofluorine. Cancer Res. 34: 2758–2763.PubMedGoogle Scholar
  108. Oliver, J. A., El Hilali, M. M., Belitsky, P., and MacKinnon, K. J., (1970). LDH isoenzymes in benign and malignant prostate tissues: The LDH V/I ratio as an index of malignancy. Cancer 25: 863–866.PubMedGoogle Scholar
  109. Parke, D. V. (1975). Induction of the drug-metabolizing enzymes. In Enzyme Induction, D. V. Parke, ed., Vol. 6 Basic Life Sciences, pp. 207–271. Plenum, London.Google Scholar
  110. Parks, W. P., Scolnick, E. M., and Kozikowski, E. H. (1974). Dexamethasone stimulation of murine mammary tumour virus expression: A tissue culture source of virus. Science 184: 158–160.PubMedGoogle Scholar
  111. Pastan, I. (1975). The role of cyclic AMP in malignant transformation. Amer. J. Clin. Pathol. 63: 669–670.Google Scholar
  112. Pastan, I., Anderson, W. A., and Johnson, G. S. (1975). Role of cyclic nucleotides in growth control. Ann. Rev. Biochem. 44: 491–522.PubMedGoogle Scholar
  113. Peraino, C., Fry, R. J. M., and Staffeldt, E. (1971). Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorine. Cancer Res. 31: 1506–1512.PubMedGoogle Scholar
  114. Peraino, C., Fry, R. J. M., Staffeldt, E., and Kisieleski, W. E. (1973). Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res. 33: 2701–2705.PubMedGoogle Scholar
  115. Pitout, M. J., and Schabort, J. C. (1973). Influence of aflatoxin B1 and aflatoxin B2 on rat liver lysosomal acid deoxyribonuclease. Biochem. Pharmac. 22: 1801–1805.Google Scholar
  116. Poirier, L. A., and Pitot, H. C. (1970a). Metabolic adaptations during carcinogenesis: Dietary induction of some enzymes of carbohydrate metabolism during 3’-methyl-and 2-methylN,N-dimethyl-4-aminoazobenzene feeding. Cancer Res. 30: 1974–1979.PubMedGoogle Scholar
  117. Poirier, L. A., and Pitot, H. C. (1970b). Dietary induction of some enzymes of amino acid metabolism following the acute administration of aminoazo dyes. Cancer Res. 30: 1980–1985.PubMedGoogle Scholar
  118. Popp, J. A., and Shinozuka, H. (1974). Inhibition of protein synthesis and induction of helical polysomes in rat liver by N-hydroxy-2-fluorenylacetamide. Chem. Biol. Interact. 9: 37–43.PubMedGoogle Scholar
  119. Pousada, C. R., and Lechner, M. C. (1972). Ribosomal and microsomal RNase activities in rat liver after methylcholanthrene administration. Biochem. Pharmacol. 21: 2563–2569.PubMedGoogle Scholar
  120. Pozharisski, K. M., Kapustin, Y. M., Likachev, A. J., and Shaposhnikov, J. D. (1975). The mechnism of carcinogenic action of 1,2-dimethylhydrazine in rats. Int. J. Cancer 15: 673–683.PubMedGoogle Scholar
  121. Radomski, J. L., and Brill, E. (1970). Bladder cancer induction by aromatic amines: Role of Nhydroxy metabolites. Science 167: 992–993.PubMedGoogle Scholar
  122. Ragnotti, G., and Aletti, M. G. (1975). The effect of phenobarbitone on protein synthesis by liver polyribosomes in fed and starved rats. Biochem. J. 146: 1–12.PubMedGoogle Scholar
  123. Roe, F. J. C., and Rowson, K. E. K. (1968). The induction of cancer by combinations of viruses and other agents. Int. Rev. Exp. Pathol. 6: 181–227.PubMedGoogle Scholar
  124. Rolleston, F. S. (1974). Membrane-bound and free ribosomes. Sub. Cell. Biochem. 3: 91–117.Google Scholar
  125. Salerno, R. A., Whitmire, C. E., Garcia, I. M., and Huebner, R. J. (1972). Chemical carcinogenesis in mice inhibited by interferon. Nature (New Biol.) 239: 31–32.Google Scholar
  126. Santti, R. S., and Villee, C. A. (1971). Hormonal control of hexokinase in male sex accessory glands. Endocrinology 89: 1162–1170.PubMedGoogle Scholar
  127. Scherstén, T., and Lundholm, K. (1972). Lysosomal enzyme activity in muscle tissue from patients with malignant tumor. Cancer 30: 1246–1251.PubMedGoogle Scholar
  128. Scherstén, T., Wahlqvist, L., and Johansson, L. G. (1969). Lysosomal enzyme activity in liver tissue from patients with renal carcinoma. Cancer 23: 608–613.PubMedGoogle Scholar
  129. Schoental, R. (1973). The mechanisms of action of the carcinogenic nitroso and related compounds. Brit. J. Cancer 28: 436–439.PubMedGoogle Scholar
  130. Schwartz, M. K. (1973). Enzymes in cancer. Clin. Chem. 19: 10–22.PubMedGoogle Scholar
  131. Segaloff, A. (1975). Steroids and carcinogenesis. J. Steroid Biochem. 6: 171–175.PubMedGoogle Scholar
  132. Shoeman, D. W., Vane, F. H., and Mannering, G. T. (1973). Differences in P-420 hemoproteins from untreated and 3-methylcholanthrene-treated rats. Drug Metab. Dispos. 1: 40–44.PubMedGoogle Scholar
  133. Sims, P. (1975). Epoxides as reactive intermediates in aromatic hydrocarbon metabolism. Biochem. Soc. Trans. 3: 59–62.PubMedGoogle Scholar
  134. Sims, P., and Grover, P. L. (1974). Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv. Cancer Res. 20: 165–274.Google Scholar
  135. Sims. P., Grover, P. L., Swaisland, A. J., Pal, K., and Hewer, A. (1974). Metabolic activation of benzo(a)pyrene proceeds via a diol epoxide. Nature (London) 252: 326–328.Google Scholar
  136. Singhal, R. L., and Ling, G. M. (1969). Metabolic control mechanisms in mammalian systems. IV. Androgenic induction of hexokinase and glucose-6-phosphate dehydrogenase in rat seminal vesicles. Canad. J. Physiol. Pharmacol. 47: 233–239.Google Scholar
  137. Sladek, N. E., and Mannering, G. J. (1966). Evidence for a new P-450 hemoprotein in hepatic microsomes from methylcholanthrene treated rats. Biochem. Biophys. Res. Commun. 24: 668–674.Google Scholar
  138. Sluyser, M. (1968). Interaction of carcinogens with histones in vitro. Biochem. Biophys. Acta 154: 606–609.Google Scholar
  139. Sluyser, M. S. (1975). Mechanism of steroid hormone action at the cellular level. In Enzyme Induction. D. V. Parke, ed. pp. 79–104. Plenum, London.Google Scholar
  140. Smith, B. J., Defendi, V., and Wigglesworth, N. M. (1973). The effect of dibutyryl cyclic AMP on transformation by oncogenic viruses. Virology 51: 230–232.PubMedGoogle Scholar
  141. Sunshine, G. H., Williams, D. J., and Rabin, B. R. (1971). Role for steroid hormones in the interaction of ribosomes with the endoplasmic membranes of rat liver. Nature (New Biol.) 230: 133–136.Google Scholar
  142. Swaisland, A. J., Grover, P. L., and Sims, P. (1974a). Reactions of polycyclic hydrocarbon epoxides with RNA and polyribonucleotides, Chem. Biol. Interact. 9: 317–326.PubMedGoogle Scholar
  143. Swaisland, A. J., Hewer, A., Pal, K., Keysell, G. R., Nooth, J., Grover, P. L., and Sims, P. (1974b). Polycyclic hydrocarbon epoxides: The involvement of 8,9-dihydro-8,9-dihydroxybenz(a)anthracene 10,11-oxide in reactions with the DNA of benz(a)anthracene treated embryo hamster cells, FEBS Lett. 47: 34–38.PubMedGoogle Scholar
  144. Swenson, D. H., Miller, E. C., and Miller, J. A. (1974). Aflatoxin B,-2,3-oxide: Evidence for its formation in rat liver in vivo and by human liver microsomes in vitro. Biochem. Biophys. Res. Commun. 3: 1036–1043.Google Scholar
  145. Szego, C. M., Seeler, B. J., Steadman, R. A., Hill, D. F., Kimura, A. K., and Roberts, J. A. (1971). The lysosomal membrane complex. Focal point of primary steroid action. Biochem. J. 123: 523–538.PubMedGoogle Scholar
  146. Tamura, Y., Niinobe, M., Arima, T., Okuda, H., and Fujii, S. (1975). Aminopeptidases and arylamidases in normal and cancer tissues in humans. Cancer Res. 35: 1030–1034.PubMedGoogle Scholar
  147. Terenius, L. (1972). Specific progesterone binder in uterus of normal rats. Steroids 19: 787–794.PubMedGoogle Scholar
  148. Trosko, J. E., Yager, J. D. Jr., Bowden, G. T., and Butcher, F. R. (1975). The effects of several croton oil constituents on two types of DNA repair and cyclic nucleotide levels in mammalian cells in vitro. Chem. Biol. Inter. 11: 191–205.Google Scholar
  149. Ulland, B. M., Weisburger, J. H., Yamamoto, R. S., and Weisberger, E. K. (1973). Antioxidants and carcinogenesis: Butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2fluorenylacetamide in rats. Food Cosmet. Toxicol. 11: 199–207.PubMedGoogle Scholar
  150. van Beek, W. P., Smets, L. A., and Emmelot, P. (1973). Increased sialic acid density in surface glycoprotein of transformed and malignant cells-A general phenomenon. Cancer Res. 33: 2913–2922.PubMedGoogle Scholar
  151. Van den Brenk, H. A. S., Kelly, H., and Orton, C. (1974). Reduction by anti-inflammatory corticosteroids of clonogenic growth of allogeneic tumour cells in normal and irradiated tissues of the rat. Brit. J. Cancer 29: 365–372.Google Scholar
  152. Van Duuren, B. L. (1969). Carcinogenic epoxides, lactones and halo-ethers and their mode of action. Ann. N.Y. Acad. Sci. 163: 633–651.Google Scholar
  153. Van Duuren, B. L., Goldschmidt, B. M., and Seltzman, H. H. (1969). The interaction of mutagenic and carcinogenic agents with nucleic acids. Ann. N.Y. Acad. Sci. 153: 744–757.PubMedGoogle Scholar
  154. van Wijk, R., Wicks, W. D., and Clay, K. (1972). Effects of derivatives of cyclic 3’,5’-adenosine monophosphate on the growth, morphology and gene expression of hepatoma cells in culture. Cancer Res. 32: 1905–1911.Google Scholar
  155. Warwick, G. P. (1969). The covalent binding of metabolites of 4-dimethylaminoazobenzene to liver nucleic acids in vivo. The possible importance of cell proliferation in cancer initiation. In Physico-chemical Mechanisms of Carcinogenesis. E. D. Bergmann and B. Pullman, eds., p. 218. Academic Press, New York.Google Scholar
  156. Weber, G., and Lea, M. A. (1966). The molecular correlation concept of neoplasia. Adv. Enzyme Regul. 4: 115–145.PubMedGoogle Scholar
  157. Weisburger, J. H., Madison, R. M., Ward, J. M., Vignera, C., and Weisburger, E. K. (1975). Modification of diethylnitrosamine liver carcinogenesis with phenobarbital but not with immunosuppresion. J. Nat. Cancer Inst. 54: 1185–1188.PubMedGoogle Scholar
  158. Weisburger, J. H., and Williams, G. M. (1975). Metabolism of chemical carcinogens. Cancer 1: 185–234.Google Scholar
  159. Weisburger, J. H., Yamamoto, R. S., Williams, G. M., Grantham, P. H., Matsushima, T., and Weisburger, E. K. (1972). On the sulphate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat. Cancer Res. 32: 491–500.PubMedGoogle Scholar
  160. Whitlock, J. P., Jr., and Gelboin, H. (1974). Aryl hydrocarbon (benz(a)pyrene) hydroxylase induction in rat liver cells in culture. J. Biol. Chem. 249: 2616–2623.PubMedGoogle Scholar
  161. Wiebel, F. J., and Gelboin, H. V. (1975). Aryl hydrocarbon (benz(a)pyrene) hydroxylases in liver from rats of different age, sex and nutritional status. Distribution of two types by 7,8-benzoflavone. Biochem. Pharmacol. 24: 1511–1515.PubMedGoogle Scholar
  162. Wilkinson, R., Hawks, A., and Pegg, A. E. (1975). Methylation of rat liver mitochondria’ DNA by chemical carcinogens and associated alterations in physical properties. Chem. Biol. Interact. 9: 157–167.Google Scholar
  163. Williams, D. C., and Smethurst, M. (1975). Enzyme induction by steroid hormones with reference to cancer. In Enzyme Induction. D. V. Parke, ed., pp. 143–168. Plenum, London.Google Scholar
  164. Yamamoto, R. S., Weisburger, J. H., and Weisburger, E. K. (1971). Controlling factors in urethan carcinogenesis in mice: Effect of enzyme inducers and metabolic inhibitors. Cancer Res. 31: 483–486.PubMedGoogle Scholar
  165. Yee, M., and Bresnick, E. (1971). Effect of administration of 3-methylcholanthrene on the salt-extractable chromatin proteins of rat liver. Mol. Pharmacol. 7: 191–198.PubMedGoogle Scholar
  166. Zieve, F. J. (1973). Effects of the carcinogen N-acetoxy-2-fluorenylacetamide on the template properties of deoxyribonucleic acid. Mol. Pharmacol. 9: 658–669.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1977

Authors and Affiliations

  • Dennis V. Parke
    • 1
  1. 1.Department of BiochemistryUniversity of SurreyGuildford, SurreyEngland

Personalised recommendations